3 articles, transcripts, and reports
CorMedix Inc (NASDAQ: CRMD) Q4 2020 earnings call dated Mar. 30, 2021. Corporate Participants: Dan Ferry — Investor Relations Khoso Baluch — Chief Executive Officer Phoebe Mounts — Executive Vice President…
— CorMedix Inc. (NYSE: CRMD) reported a fourth-quarter 2019 loss of $0.21 per share versus a loss of $0.24 per share expected. — The latest…
— CorMedix, Inc. (NYSE: CRMD) reported a net loss attributable to common shareholders of $32.4 million or $1.35 per share for the third quarter, compared…
